Xu, Liangliang
Feng, Xinfu
Hao, Xiangyong
Wang, Peng
Zhang, Yanfang
Zheng, Xiaobo
Li, Lian
Ren, Shengsheng
Zhang, Ming
Xu, Mingqing
Funding for this research was provided by:
National Natural Science Foundation of China (71673193)
Key Technology Research and Development Program of the Sichuan Province (2015SZ0131)
Key Technology Research and Development Program of the Sichuan Province (2017FZ0082)
Key Technology Research and Development Program of the Sichuan Province (19ZDYF1740)
Natural Science Foundation for Young Scientists and the Science & Technology Planning Project of Gansu Province (18JR3RA058)
Chinese foundation for hepatitis prevention and control——TianQing liver disease research fund subject (TQGB20190202)
Article History
Received: 12 September 2018
Accepted: 15 January 2019
First Online: 22 February 2019
Ethics approval and consent to participate
: The collection of human specimens was approved by the Biomedical Ethics Committee of West China Hospital and the written informed consent were obtained from each patient.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.